Page last updated: 2024-08-23

substance p and Leucocythaemia

substance p has been researched along with Leucocythaemia in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19902 (33.33)18.7374
1990's1 (16.67)18.2507
2000's2 (33.33)29.6817
2010's1 (16.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cao, Y; Chen, Q; Fu, C; Ge, C; Huang, F; Huang, H; Kang, J; Liu, L; Pearson, RB; Shi, Y; Sun, Y; Wang, X; Wu, H; Yang, T; Zhang, T; Zhou, H1
Konwerska, A; Miskowiak, B; Nowicki, M; Ostalska-Nowicka, D1
Kondraciuk, B; Miskowiak, B; Nowicki, M; Ostalska-Nowicka, D1
Goetzl, EJ; Payan, DG1
Munekata, E; Takenouchi, T1
Chernov, T; Goetzl, EJ; Payan, DG; Renold, F1

Reviews

1 review(s) available for substance p and Leucocythaemia

ArticleYear
The significance of substance P in physiological and malignant haematopoiesis.
    Journal of clinical pathology, 2007, Volume: 60, Issue:7

    Topics: Antineoplastic Agents; Bone Marrow; Cell Transformation, Neoplastic; Hematopoiesis; Humans; Leukemia; Neoplasm Metastasis; Neoplasm Proteins; Neoplasms; Substance P; Tachykinins

2007

Other Studies

5 other study(ies) available for substance p and Leucocythaemia

ArticleYear
Neurokinin-1 receptor is an effective target for treating leukemia by inducing oxidative stress through mitochondrial calcium overload.
    Proceedings of the National Academy of Sciences of the United States of America, 2019, 09-24, Volume: 116, Issue:39

    Topics: Adult; Aged; Animals; Apoptosis; Calcium; Cell Line, Tumor; Female; Humans; Inflammation; Leukemia; Leukemia, Myeloid, Acute; Male; Mice; Mice, Inbred ICR; Middle Aged; Mitochondria; Neurokinin-1 Receptor Antagonists; Oxidative Stress; Receptors, Neurokinin-1; Signal Transduction; Substance P

2019
The predicting role of substance P in the neoplastic transformation of the hypoplastic bone marrow.
    Journal of clinical pathology, 2006, Volume: 59, Issue:9

    Topics: Adolescent; B-Lymphocytes; Bone Marrow Diseases; Bone Marrow Examination; Cell Transformation, Neoplastic; Child; Child, Preschool; Disease Progression; Humans; Immunoenzyme Techniques; Immunophenotyping; In Situ Hybridization; Ki-67 Antigen; Leukemia; Leukemia, Myeloid, Acute; Neoplasm Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis; Substance P

2006
Inhibition by somatostatin of the release of mediators from human basophils and rat leukemic basophils.
    Journal of immunology (Baltimore, Md. : 1950), 1984, Volume: 133, Issue:6

    Topics: Animals; Antibodies, Anti-Idiotypic; Basophils; Dose-Response Relationship, Immunologic; Histamine Release; Humans; Immunoglobulin E; Immunosuppressive Agents; Leukemia; Peptides; Rats; Somatostatin; SRS-A; Substance P

1984
Trophic effects of substance P and beta-amyloid peptide on dibutyryl cyclic AMP-differentiated human leukemic (HL-60) cells.
    Life sciences, 1995, Volume: 56, Issue:26

    Topics: Amino Acid Sequence; Amyloid beta-Peptides; Bucladesine; Calcium; Cell Differentiation; Cell Survival; Culture Media, Serum-Free; Humans; L-Lactate Dehydrogenase; Leukemia; Molecular Sequence Data; Peptide Fragments; Substance P; Superoxides; Tumor Cells, Cultured

1995
Neuropeptide regulation of the expression of immediate hypersensitivity.
    Journal of immunology (Baltimore, Md. : 1950), 1985, Volume: 135, Issue:2 Suppl

    Topics: Basophils; Endorphins; Humans; Hypersensitivity, Immediate; Leukemia; Mast Cells; Nerve Tissue Proteins; Neurotensin; Neurotransmitter Agents; Somatostatin; Substance P; Vasoactive Intestinal Peptide

1985